AI Article Synopsis
- The study aimed to determine if serum levels of pregnancy-associated plasma protein A (PAPP-A) are elevated in patients with acute myocardial infarction (AMI).
- Researchers measured PAPP-A levels in 80 AMI patients and 80 healthy controls, finding no significant difference in levels (1.24 vs. 1.29 mIU/l; P = 0.54).
- The findings suggest that serum PAPP-A may not be a valuable early indicator for diagnosing AMI.
Article Abstract
Objective: The purpose of this study was to assess whether serum levels of pregnancy-associated plasma protein A (PAPP-A) are elevated early in patients with acute myocardial infarction (AMI).
Design And Methods: We measured serum levels of PAPP-A in 80 patients with AMI and in 80 age-matched healthy control subjects. The mean (+/-SEM) time from onset of symptoms to blood sampling was 6.3 +/- 2.8 h in the group with AMI.
Results: The PAPP-A levels did not differ between the control group and the AMI group (1.24 +/- 0.07 vs. 1.29 +/- 0.02 mIU/l; P = 0.54).
Conclusions: Measurement of serum PAPP-A does not seem to be a useful early marker for AMI.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clinbiochem.2004.10.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!